UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000059202
Receipt number R000067713
Scientific Title Research on hair root responsiveness and hair growth effects
Date of disclosure of the study information 2025/09/26
Last modified on 2025/09/26 14:42:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research on hair root responsiveness and hair growth effects

Acronym

Research on hair root responsiveness and hair growth effects

Scientific Title

Research on hair root responsiveness and hair growth effects

Scientific Title:Acronym

Research on hair root responsiveness and hair growth effects

Region

Japan


Condition

Condition

Not applicable

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the relationship between the responsiveness of hair follicles and hair growth effects.

Basic objectives2

Others

Basic objectives -Others

To determine the relationship between the responsiveness of hair follicles and hair growth efficacy.

Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

The relation with the rate of hair diameter changes and hair root genes before and after 16 weeks of use of test products.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

4

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Apply hair growth product to the right side of the head twice a day for 16wks.

Interventions/Control_2

Apply hair growth product to the left side of the head twice a day for 16wks.

Interventions/Control_3

Apply placebo to the right side of the head twice a day for 16wks.

Interventions/Control_4

Apply placebo to the left side of the head twice a day for 16wks.

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

59 years-old >=

Gender

Male

Key inclusion criteria

1. Japanese male aged 20-59.
2. Those whose hair condition corresponds to II vertex, II, IIa, III vertex, III, IIIa, IV, or IVa according to the Hamilton-Norwood classification.
3. Those who are not using anti hair loss products at the time of recruitment into the study, or who agree to discontinue using them from the time of receiving an explanation of the study.

Key exclusion criteria

1. Those who have allergic reactions to ethanol on the skin.
2. Those who have surgical scars on the head.
3. Those who have skin symptoms such as atopic dermatitis, contact dermatitis, seborrheic dermatitis, etc. on the scalp.
4. Those who have undergone chemical treatment of the hair within the past one month from the time of recruitment.
5. Those who are experiencing acute hair loss or hair falling out in patches.
6. Those whose gray hair ratio exceeds that of black hair when not dyed.
7. Those who are skinhead or short hair less than 4 cm in length.
8. Those who have undergone hair transplantation or hair extension.
9. Those who have used any medicines including hair regrowth agents on the scalp in the past one month.
10. Those who have orally ingested any drug that shows hair regrowth effect in the past one month.
11. Those who regularly take supplements that may have an effect of reducing skin inflammation.
12. Those who regularly take supplements that may improve or prevent hair loss.
13. Those who have a history or current history of serious illnesses such as diabetes, liver disease, renal disease, or cardiac disease.
14. Those who have received any vaccination within 2 weeks prior to the start of participation in the study.
15. Those who are planning to participate in other clinical trials or monitoring surveys during the study period.
16. Those who is otherwise deemed inappropriate as a research subject by the person in charge of conducting the research.

Target sample size

24


Research contact person

Name of lead principal investigator

1st name Katsuyuki
Middle name
Last name Yuki

Organization

Kao Corporation

Division name

Hair Care Research Lab.

Zip code

131-8501

Address

2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, JAPAN

TEL

+81-3-5630-9395

Email

yuki.katsuyuki@kao.com


Public contact

Name of contact person

1st name Tamaki
Middle name
Last name Hirano

Organization

Kao Corporation

Division name

Hair Care Research Lab.

Zip code

131-8501

Address

2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, JAPAN

TEL

+81-3-5630-9395

Homepage URL


Email

hirano.tamaki@kao.com


Sponsor or person

Institute

Kao Corporation

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Human Research Ethics Committee, Kao Corporation

Address

2-1-3 Bunka, Sumida-ku, Tokyo 131-8501, JAPAN

Tel

+81-3-5630-9064

Email

morisaki.naoko@kao.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 09 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 09 Month 16 Day

Date of IRB

2025 Year 09 Month 16 Day

Anticipated trial start date

2025 Year 09 Month 26 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 09 Month 26 Day

Last modified on

2025 Year 09 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067713